Safety assessment
ADVERSE EVENTS
The medical history of each participant was recorded at the initial screening visit. The safety of the test supplements was assessed by monitoring adverse events, vital signs, clinical laboratory findings, and lengths of menstrual cycles. Additionally, the rate of change in plasma volume from E-D1 morning to E-D3 morning was calculated using hemoglobin and hematocrit values as described by Dill and Costill [